Global Pricing Innovations (GPI) is a market leader in price and market access insights, supporting pharma and biotech companies to maximize product value for patients through dynamic pricing and market access solutions. Headquartered in London, GPI provides a best-in-class data analytics platform and consulting services, offering evidence-based decision support to help clients make better investment decisions. With GPI Horizon, the company boasts the only value assessment and price prediction platform on the market. The team of leading domain specialists at GPI provides high quality, curated, and rapid insights, making recommendations on global drug pricing strategy, market access optimization, asset evaluation, value perception, and payer analytics. GPI's suite of technology and bespoke service offerings are powered by GPI Pulse™, a solution harnessing the power of technology, data, and collective expertise to produce rapid insights. The company's culture focuses on the success of its customers, with a passionate team dedicated to bringing energy, enthusiasm, and expertise into everything they do. Visit www.globalpricing.com for more about their innovative solutions and career opportunities. Founded in 2015, GPI operates in the Analytics and Biopharma industries.
There is no investment information
No recent news or press coverage available for Global Pricing Innovations (GPI).